INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

76,378 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
703 sh
Jun 5, 2026Jun 9, 2026
Page 847 of 1910
← PrevNext →
traded Jun 5, 2026
+4d
SEC Form 4

Evidence

5
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Option exercise
M—
2,278 sh
Jun 7, 2026Jun 9, 2026
traded Jun 7, 2026
+2dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
24.7K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$986
463 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
560 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
GR
Gray Nancy RyanDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
2,938 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
2,409 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
AC
Amara CarmenChief People Officer
YELPYELP INC
Open-market sale · 10b5-1 plan
SELL$24K
1,000 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
RR
Ricker Sean RaymondChief Financial Officer
BBAIBigBear.ai Holdings, Inc.
Tax withholding
F$41K
9,759 sh
Jun 6, 2026Jun 9, 2026
traded Jun 6, 2026
+3dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
47.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Tax withholding
F$38K
1,102 sh
Jun 7, 2026Jun 9, 2026
traded Jun 7, 2026
+2dSEC Form 4

Evidence

5
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$28K
1,292 sh
Jun 6, 2026Jun 9, 2026
traded Jun 6, 2026
+3dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$13K
319 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
718 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
KA
Kang AndrewEVP & CFO
MSTRStrategy Inc
Open-market sale · 10b5-1 plan
SELL$2,498
20 sh
Jun 9, 2026Jun 9, 2026
traded Jun 9, 2026
+0dSEC Form 4

Evidence

5
ZD
Zugelder DanEVP, Chief Revenue Officer
DTDynatrace, Inc.
Option exercise
M—
4,043 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
24.7K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
47.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
ZD
Zugelder DanEVP, Chief Revenue Officer
DTDynatrace, Inc.
Grant or award
A—
61.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
WT
Wettig ThaneDirector, CEO
KYNBKYNTRA BIO, INC.
Tax withholding
F$1,329
198 sh
Jun 6, 2026Jun 9, 2026
traded Jun 6, 2026
+3dSEC Form 4

Evidence

5
MA
McMahon Stephen AEVP, Chief Customer Officer
DTDynatrace, Inc.
Grant or award
A—
37.9K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
836 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$50K
1,185 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
10.0K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Grant or award
A—
8,889 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$11K
249 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$45K
1,069 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
ZD
Zugelder DanEVP, Chief Revenue Officer
DTDynatrace, Inc.
Option exercise
M—
13.9K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$13K
312 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
2,938 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
CL
CP BF Lending, LLC10% Owner
BNZIBanzai International, Inc.
Derivative conversion
C—
5,079 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
CL
CP BF Lending, LLC10% Owner
BNZIBanzai International, Inc.
Derivative conversion
C—
30.7K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
ZD
Zawitz DavidChief Operating Officer
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
171.3K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
RJ
Rieger JaysonDirector, CEO and President
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
512.3K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

4
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

3
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M$95K
44.0K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

3
NS
Neville Patrick SeanDirector
CRCLCircle Internet Group, Inc.
Derivative conversion · 10b5-1 plan
C—
1.03M sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

3
KA
Kang AndrewEVP & CFO
MSTRStrategy Inc
Option exercise · 10b5-1 plan
M—
4,260 sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

2
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
836 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

2
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
2,938 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence